Sporadic cerebral small vessel disease and cognitive decline in healthy older adults: A systematic review and meta-analysis

Abstract

We performed a systematic review and meta-analysis on prospective studies that provided risk estimates for the impact of 3 different MRI markers of small vessel disease (SVD), namely white matter hyperintensities (WMH), cerebral microbleeds (CMB) and lacunes, on cognitive decline in relatively healthy older adults without cognitive deficits at baseline. A total of 23 prospective studies comprising 11,486 participants were included for analysis. Extracted data was pooled, reviewed and meta-analysed separately for global cognition, executive function, memory and attention. The pooled effect size for the association between cerebral SVD and cognitive decline was for global cognition −0.10 [−0.14; −0.05], for executive functioning −0.18 [−0.24; − 0.11], for memory −0.12 [−0.17; −0.07], and for attention −0.17 [−0.23; −0.11]. Results for the association of individual MRI markers of cerebral SVD were statistically significant for WMH and global cognition −0.15 [−0.24; −0.06], WMH and executive function −0.23 [−0.33; −0.13], WMH and memory −0.19 [−0.29; −0.09], WMH and attention −0.24 [−0.39; −0.08], CMB and executive function −0.07 [−0.13; −0.02], CMB and memory −0.11 [−0.21; −0.02] and CMB and attention −0.13 [−0.25; −0.02]. In conclusion, presence of MRI markers of cerebral SVD were found to predict an increased risk of cognitive decline in relatively healthy older adults. While WMH were found to significantly affect all cognitive domains, CMB influenced decline in executive functioning over time as well as (in some studies) decline in memory and attention.